BioSpace News Archive

Business

PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update

PolarityTE to host conference call and webcast today, May 16, 2022 , at 8:30 a.m. ET.

May 16, 2022
·
20 min read
Genetown

Factor Bioscience to Deliver Four Presentations at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting

Factor Bioscience Inc., a Cambridge -based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting to be held in Washington, D.C. from May 16-19, 2022.

May 16, 2022
·
1 min read
Business

Matthew Rabinowitz, Natera Co-Founder and Executive Chairman of the Board, Makes Additional Investment in Natera

Natera, Inc. announced that Matthew Rabinowitz, co-founder and Executive Chairman of Natera, together with his family’s trust, have recently acquired a total of 470,000 shares of Natera stock through the purchase of additional shares on the open market and from the exercise of stock options.

May 16, 2022
·
3 min read
Business

AcelRx Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its first quarter 2022 financial results.

May 16, 2022
·
13 min read
Numinus Wellness Receives Health Canada Special Access Program Applicant Approval to Provide Psychedelic-assisted Therapy Treatment

Approval Marks Numinus’ First use of Psilocybin-Assisted Therapy Treatment Outside of Clinical Trials.

May 16, 2022
·
4 min read
Business

Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update

Syros Pharmaceuticals today reported financial results for the quarter ended March 31, 2022 and provided a corporate update.

May 16, 2022
·
10 min read
Business

RenovoRx Reports First Quarter 2022 Financial Results

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is reporting its financial results for the quarter ended March 31, 2022.

May 16, 2022
·
7 min read
Business

Miravo Healthcare™ Announces First Quarter 2022 Results

Miravo Healthcare ™ Announces First Quarter 2022 Results.

May 16, 2022
·
15 min read
Business

Eikon Therapeutics Announces the Election of Robin L. Washington to Its Board of Directors

Eikon Therapeutics Announces the Election of Robin L. Washington to Its Board of Directors.

May 16, 2022
·
3 min read
Business

ALDEVRON LICENSES THE MANUFACTURING OF A TYPE-V CRISPR NUCLEASE FROM INSCRIPTA

A partnership between two CRISPR pioneers will provide the global scientific community with GMP MAD7™ Nuclease.

May 16, 2022
·
3 min read